DrugPatentWatch Database Preview
Investigational Drug Information for Ecopipam
Email this page to a colleague
What is the development status for investigational drug Ecopipam?
Ecopipam is an investigational drug.
There have been 14 clinical trials for Ecopipam.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2012.
The most common disease conditions in clinical trials are Syndrome, Tourette Syndrome, and Self-Injurious Behavior. The leading clinical trial sponsors are Psyadon Pharma, Emalex Biosciences Inc., and Syneos Health.
There are two hundred and nine US patents protecting this investigational drug and one international patent.
Summary for Ecopipam
| US Patents | 209 |
| International Patents | 1,915 |
| US Patent Applications | 422 |
| WIPO Patent Applications | 292 |
| Japanese Patent Applications | 209 |
| Clinical Trial Progress | Phase 2 (2012-12-01) |
| Vendors | 11 |
Recent Clinical Trials for Ecopipam
| Title | Sponsor | Phase |
|---|---|---|
| Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite | Nuventra | Phase 1 |
| Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite | Syneos Health | Phase 1 |
| Drug-Drug Interaction Study to Evaluate the Effect of Inhibition of UGTs on the PK of Ecopipam and Its Active Metabolite | Emalex Biosciences Inc. | Phase 1 |
Clinical Trial Summary for Ecopipam
Top disease conditions for Ecopipam
Top clinical trial sponsors for Ecopipam
US Patents for Ecopipam
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Ecopipam | ⤷ Try it Free | Compositions and methods for diagnosis and treatment of metabolic syndrome | The United States of America, as Represented by the Secretary of the Navy (Washington, DC) | ⤷ Try it Free |
| Ecopipam | ⤷ Try it Free | Biguanide compositions and methods of treating metabolic disorders | ELCELYX THERAPEUTICS, INC. (San Diego, CA) | ⤷ Try it Free |
| Ecopipam | ⤷ Try it Free | WT1 peptide cancer vaccine composition for transdermal administration | NITTO DENKO CORPORATION (Osaka, JP) OSAKA UNIVERSITY (Osaka, JP) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Ecopipam
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Ecopipam | Argentina | AR103371 | 2035-01-07 | ⤷ Try it Free |
| Ecopipam | European Patent Office | EP3247346 | 2035-01-07 | ⤷ Try it Free |
| Ecopipam | Japan | JP2018505158 | 2035-01-07 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
